GCGM
GUTS icon

General Catalyst Group Management’s Fractyl Health GUTS Stock Holding History

General Catalyst Group Management’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.88M Sell
4,884,186
-7
-0% -$5 2.06% 7
2026
Q1 		$2.24M Hold
4,884,193
– – 1.22% 7
2025
Q4 		$10.7M Hold
4,884,193
– – 4.85% 6
2025
Q3 		$7.77M Hold
4,884,193
– – 0.26% 8
2025
Q2 		$7.91M Buy
+4,884,193
New +$7.89M 0.18% 8

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

General Catalyst Group Management's GUTS Position: Q2 2026 in Review

General Catalyst Group Management reduced its Fractyl Health (GUTS) stake by 0% in Q2 2026, selling an estimated $5 and leaving 4,884,186 shares worth $3.88M. The position accounts for 2.06% of the portfolio, ranked #7.

General Catalyst Group Management first reported a position in GUTS in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.7M in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • General Catalyst Group Management held 4,884,186 shares of Fractyl Health worth $3.88M as of Q2 2026.
  • General Catalyst Group Management sold 7 Fractyl Health shares in Q2 2026, an estimated $5.
  • Fractyl Health made up 2.06% of General Catalyst Group Management's portfolio in Q2 2026, its #7 holding.
  • General Catalyst Group Management first reported a position in Fractyl Health in Q2 2025 and has held it in 5 quarters since.
  • General Catalyst Group Management's Fractyl Health position peaked at $10.7M in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on General Catalyst Group Management's 13F filing for Q2 2026, filed 17 Aug 2026.